$10.25
+0.05 (+0.49%)
Open$10.18
Previous Close$10.20
Day High$10.25
Day Low$10.16
52W High$17.20
52W Low$9.50
Volume—
Avg Volume61.8K
Market Cap321.40M
P/E Ratio46.65
EPS$0.14
SectorN/A
Analyst Ratings
Strong Buy
6 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 63.22M | 66.33M | 66.97M |
| Net Income | 7.61M | 7.36M | 6.38M |
| Profit Margin | 12.0% | 11.1% | 9.5% |
| EBITDA | 9.86M | 10.37M | 9.59M |
| Free Cash Flow | 5.27M | 5.23M | 4.88M |
| Rev Growth | +23.9% | +15.1% | +6.4% |
| Debt/Equity | 0.30 | 0.36 | 0.34 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.20 | +0.00% | — | 2.01B |
| PICS | Pics Nv | $8.32 | -4.26% | 4.4 | 1.13B |
| DMII | Drugs Made In America Acquis | $10.16 | +0.10% | 49.7 | 646.56M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.76 | +0.47% | 42.2 | 335.42M |
| CEPF | Cantor Equity Partners-Cl A | $10.30 | +0.15% | 41.3 | 587.79M |